Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 781 clinical trials
Featured trial
A 5 day course of an investigational antiviral tablet for those positive to RSV.

5 visits over 2 weeks testing an investigational medication for RSV. Must be between 18-75 years and experiencing cold and flu like symptoms.  

  • 120 views
  • 23 Nov, 2020
  • 1 location
Featured trial
RSV Vaccine

VOLUNTEERS NEEDED FOR AN RSV VACCINE STUDYOlder adults are more likely to develop serious complications from a cold-like virus called Respiratory Syncytial Virus (RSV). Join a clinical

  • 0 views
  • 03 Dec, 2021
  • 1 location
Featured trial
RSV Vaccine

VOLUNTEERS NEEDED FOR AN RSV VACCINE STUDYOlder adults are more likely to develop serious complications from a cold-like virus called Respiratory Syncytial Virus (RSV). Join a clinical

  • 4 views
  • 18 Feb, 2022
  • 1 location
Featured trial
Upper Respiratory Symptoms Research Study

Upper Respiratory Symptoms Research Study

  • 624 views
  • 23 Nov, 2020
  • 1 location
Feasibility and Effects of Taking Cold Showers: A Randomized Controlled Study

Considering the beneficial individual and environmental effects, investigators set out to replicate the recent study on the effects of taking cold showers on sickness absence, illness days and

Accepts healthy volunteers
  • 155 views
  • 19 Feb, 2022
  • 1 location
Dupilumab for the Treatment of Chronic Inducible Cold Urticaria in Patients Who Remain Symptomatic Despite the Use of H1-antihistamine (LIBERTY-CINDU CUrIADS)

Primary Objective: To demonstrate the efficacy of dupilumab in adult and adolescent participants with primary acquired chronic inducible cold urticaria (ColdU) who remain symptomatic

  • 0 views
  • 29 Jul, 2022
  • 30 locations
Dupilumab for the Treatment of Chronic Inducible Cold Urticaria in Patients Who Remain Symptomatic Despite the Use of H1-antihistamine (LIBERTY-CINDU CUrIADS)

Primary Objective: To demonstrate the efficacy of dupilumab in adult and adolescent participants with primary acquired chronic inducible cold urticaria (ColdU) who remain symptomatic

  • 58 views
  • 10 Aug, 2022
  • 30 locations
Arbidol for COPD Exacerbations

immediately. The subjects are required to receive the first dose of drug within 8 hours after the symptoms of upper respiratory tract infection.

  • 0 views
  • 23 Jan, 2021
  • 1 location
Generating Collective Solutions to Reduce Unnecessary Antibiotic Use in Vietnam

respiratory infections (ARI) in primary care, and then training primary healthcare doctors in their use. The third intervention arm will have basic antimicrobial stewardship guidelines and training for

Accepts healthy volunteers
  • 0 views
  • 02 May, 2022
  • 1 location
A Study to Compare Sitavig (Acyclovir) Buccal Tablet With a Placebo in the Treatment of Herpes Labialis in Participants Whose Immune System Works Normally

Researchers are looking for a better way to treat people who have recurrent herpes labialis, also known as cold sores. This is a type of viral infection that causes redness and blisters on the

  • 0 views
  • 25 Jul, 2022
  • 1 location